Investors Are Craving More from UnitedHealth Group Incorporated [UNH] Stocks: Here is Why

UnitedHealth Group Incorporated [UNH] has traded in a range of $187.72 to $367.95 in the last 1 year. As of this writing, the stock is at $348.68, up 0.32%. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, UNH shares are 4.65% up with the monthly amount drift of 8.50% and seems well in a long time frame.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


On 3, December 2020, UnitedHealthcare Awards Nearly $100,000 in Community Builder Grants to Six Community Organizations in Michigan. According to news published on Yahoo Finance, Grants ranging from $10,000 to $25,000 will support programs that address:.

Analyst Birdseye View:

The most recent analyst activity for UnitedHealth Group Incorporated [NYSE:UNH] stock was on July 01, 2020, when it was Resumed with an Outperform rating from SVB Leerink, which also raised its 12-month price target on the stock to $360. On June 05, 2020, Goldman Initiated a Buy rating and boosted its price target on this stock to $384. On March 20, 2020, Deutsche Bank Upgrade a Buy rating and increased its price target to $308. On October 18, 2019, Mizuho Initiated a Buy rating and increased its price target to $270. On October 10, 2019, Jefferies Downgrade a Hold rating and boosted its amount target on this stock to $235. On September 30, 2019, BMO Capital Markets Downgrade a Market perform rating and decreased its target amount on this stock from $292 to $249.

In the past 52 weeks of trading, this stock has oscillated between a low of $187.72 and a peak of $367.95. Right now, according to Wall Street analyst the average 12-month amount target is $386.08. At the most recent market close, shares of UnitedHealth Group Incorporated [NYSE:UNH] were valued at $348.68. According to the average price forecast, investors can expect a potential return of 2.53%.


UnitedHealth Group Incorporated [NYSE:UNH] most recently reported quarterly sales of 65.11 billion, which represented growth of 7.90%. This publicly-traded organization’s revenue is $745,092 per employee, while its income is $42,582 per employee. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at 8.36, 25.32, 20.09 and 15.05 respectively.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 43.65 and the whole liability to whole assets at 25.25. It shows enduring liability to the whole principal at 39.08 and enduring liability to assets at 0.23 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 345.86 points at 1st support level, the second support level is making up to 343.03. But as of 1st resistance point, this stock is sitting at 352.14 and at 355.59 for 2nd resistance point.

UnitedHealth Group Incorporated [UNH] reported its earnings at $3.51 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at $3.09/share signifying the difference of 0.42 and 13.60% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were $7.12 calling estimates for $5.28/share with the difference of 1.84 depicting the surprise of 34.80%.

Now if looking for a valuation of this stock’s amount to sales ratio it’s 1.17, it’s amount to book ratio is 4.84 and showing 20.04 of P/E (TTM) ratio.

Insider Stories

The most recent insider trade was by BURKE RICHARD T, Director, and it was the sale of 10000.0 shares on Nov 06. HEMSLEY STEPHEN J, the Director, completed a sale of 98579.0 shares on Oct 23. On Aug 28, SHORT MARIANNE D, EVP & Chief Legal Officer, completed a sale of 10336.0 shares.